These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35361921)

  • 1. DNA methylation signature associated with Bohring-Opitz syndrome: a new tool for functional classification of variants in ASXL genes.
    Awamleh Z; Chater-Diehl E; Choufani S; Wei E; Kianmahd RR; Yu A; Chad L; Costain G; Tan WH; Scherer SW; Arboleda VA; Russell BE; Weksberg R
    Eur J Hum Genet; 2022 Jun; 30(6):695-702. PubMed ID: 35361921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANKRD11 pathogenic variants and 16q24.3 microdeletions share an altered DNA methylation signature in patients with KBG syndrome.
    Awamleh Z; Choufani S; Cytrynbaum C; Alkuraya FS; Scherer S; Fernandes S; Rosas C; Louro P; Dias P; Neves MT; Sousa SB; Weksberg R
    Hum Mol Genet; 2023 Apr; 32(9):1429-1438. PubMed ID: 36440975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into DNA methylation signatures: SMARCA2 variants in Nicolaides-Baraitser syndrome.
    Chater-Diehl E; Ejaz R; Cytrynbaum C; Siu MT; Turinsky A; Choufani S; Goodman SJ; Abdul-Rahman O; Bedford M; Dorrani N; Engleman K; Flores-Daboub J; Genevieve D; Mendoza-Londono R; Meschino W; Perrin L; Safina N; Townshend S; Scherer SW; Anagnostou E; Piton A; Deardorff M; Brudno M; Chitayat D; Weksberg R
    BMC Med Genomics; 2019 Jul; 12(1):105. PubMed ID: 31288860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the phenotypic spectrum of ASXL-related disease: Ten cases and a review of the literature.
    Cuddapah VA; Dubbs HA; Adang L; Kugler SL; McCormick EM; Zolkipli-Cunningham Z; Ortiz-González XR; McCormack S; Zackai E; Licht DJ; Falk MJ; Marsh ED
    Am J Med Genet A; 2021 Jun; 185(6):1700-1711. PubMed ID: 33751773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells.
    Awamleh Z; Choufani S; Wu W; Rots D; Dingemans AJM; Nadif Kasri N; Boronat S; Ibañez-Mico S; Cuesta Herraiz L; Ferrer I; Martínez Carrascal A; Pérez-Jurado LA; Aznar Lain G; Ortigoza-Escobar JD; de Vries BBA; Koolen DA; Weksberg R
    Eur J Hum Genet; 2024 Mar; 32(3):324-332. PubMed ID: 38282074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants.
    Siu MT; Butcher DT; Turinsky AL; Cytrynbaum C; Stavropoulos DJ; Walker S; Caluseriu O; Carter M; Lou Y; Nicolson R; Georgiades S; Szatmari P; Anagnostou E; Scherer SW; Choufani S; Brudno M; Weksberg R
    Clin Epigenetics; 2019 Jul; 11(1):103. PubMed ID: 31311581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the neurodevelopmental and motor phenotypes of Bohring-Opitz syndrome (ASXL1) and Bainbridge-Ropers syndrome (ASXL3).
    Ayoub MC; Anderson JT; Russell BE; Wilson RB
    Front Neurosci; 2023; 17():1244176. PubMed ID: 38027485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.
    Shashi V; Pena LD; Kim K; Burton B; Hempel M; Schoch K; Walkiewicz M; McLaughlin HM; Cho M; Stong N; Hickey SE; Shuss CM; ; Freemark MS; Bellet JS; Keels MA; Bonner MJ; El-Dairi M; Butler M; Kranz PG; Stumpel CT; Klinkenberg S; Oberndorff K; Alawi M; Santer R; Petrovski S; Kuismin O; Korpi-Heikkilä S; Pietilainen O; Aarno P; Kurki MI; Hoischen A; Need AC; Goldstein DB; Kortüm F
    Am J Hum Genet; 2016 Oct; 99(4):991-999. PubMed ID: 27693232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of CD96 and ASXL1 in 11 patients with Opitz C or Bohring-Opitz syndromes.
    Urreizti R; Roca-Ayats N; Trepat J; Garcia-Garcia F; Aleman A; Orteschi D; Marangi G; Neri G; Opitz JM; Dopazo J; Cormand B; Vilageliu L; Balcells S; Grinberg D
    Am J Med Genet A; 2016 Jan; 170A(1):24-31. PubMed ID: 26768331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and cancer genomics of ASXL family members.
    Katoh M
    Br J Cancer; 2013 Jul; 109(2):299-306. PubMed ID: 23736028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic ASXL1 somatic variants in reference databases complicate germline variant interpretation for Bohring-Opitz Syndrome.
    Carlston CM; O'Donnell-Luria AH; Underhill HR; Cummings BB; Weisburd B; Minikel EV; Birnbaum DP; ; Tvrdik T; MacArthur DG; Mao R
    Hum Mutat; 2017 May; 38(5):517-523. PubMed ID: 28229513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical findings in 39 individuals with Bohring-Opitz syndrome from a global patient-driven registry with implications for tumor surveillance and recurrence risk.
    Russell BE; Kianmahd RR; Munster C; Yu A; Ahad L; Tan WH
    Am J Med Genet A; 2023 Apr; 191(4):1050-1058. PubMed ID: 36751885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiomics of Bohring-Opitz syndrome truncating ASXL1 mutations identify canonical and noncanonical Wnt signaling dysregulation.
    Lin I; Wei A; Awamleh Z; Singh M; Ning A; Herrera A; ; Russell BE; Weksberg R; Arboleda VA
    JCI Insight; 2023 May; 8(10):. PubMed ID: 37053013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An HNRNPK-specific DNA methylation signature makes sense of missense variants and expands the phenotypic spectrum of Au-Kline syndrome.
    Choufani S; McNiven V; Cytrynbaum C; Jangjoo M; Adam MP; Bjornsson HT; Harris J; Dyment DA; Graham GE; Nezarati MM; Aul RB; Castiglioni C; Breckpot J; Devriendt K; Stewart H; Banos-Pinero B; Mehta S; Sandford R; Dunn C; Mathevet R; van Maldergem L; Piard J; Brischoux-Boucher E; Vitobello A; Faivre L; Bournez M; Tran-Mau F; Maystadt I; Fernández-Jaén A; Alvarez S; García-Prieto ID; Alkuraya FS; Alsaif HS; Rahbeeni Z; El-Akouri K; Al-Mureikhi M; Spillmann RC; Shashi V; Sanchez-Lara PA; Graham JM; Roberts A; Chorin O; Evrony GD; Kraatari-Tiri M; Dudding-Byth T; Richardson A; Hunt D; Hamilton L; Dyack S; Mendelsohn BA; Rodríguez N; Sánchez-Martínez R; Tenorio-Castaño J; Nevado J; Lapunzina P; Tirado P; Carminho Amaro Rodrigues MT; Quteineh L; Innes AM; Kline AD; Au PYB; Weksberg R
    Am J Hum Genet; 2022 Oct; 109(10):1867-1884. PubMed ID: 36130591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of DNA Methylation Signatures and Classification of Variants in Rare Neurodevelopmental Disorders Using EpigenCentral.
    Awamleh Z; Goodman S; Kallurkar P; Wu W; Lu K; Choufani S; Turinsky AL; Weksberg R
    Curr Protoc; 2022 Nov; 2(11):e597. PubMed ID: 36367395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel splicing mutation in the ASXL3 gene causing Bainbridge-Ropers syndrome.
    Hori I; Miya F; Ohashi K; Negishi Y; Hattori A; Ando N; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Saitoh S
    Am J Med Genet A; 2016 Jul; 170(7):1863-7. PubMed ID: 27075689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional Sex Combs-like Family Associated with Epigenetic Regulation.
    Kim N; Byun S; Um SJ
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bohring-Opitz syndrome caused by an ASXL1 mutation inherited from a germline mosaic mother.
    Bedoukian E; Copenheaver D; Bale S; Deardorff M
    Am J Med Genet A; 2018 May; 176(5):1249-1252. PubMed ID: 29681100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.
    Katoh M
    Expert Rev Proteomics; 2015 Jun; 12(3):317-28. PubMed ID: 25835095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of ASXL3 gene in silico.
    Katoh M; Katoh M
    Int J Oncol; 2004 Jun; 24(6):1617-22. PubMed ID: 15138607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.